Mega Lifesciences Public Company Limited (MEGA) — Cash Flow-to-Debt Ratio
Mega Lifesciences Public Company Limited (MEGA) has a Cash Flow-to-Debt Ratio of 0.11x as of June 2025, meaning its operating cash flow of ฿461.26 Million could theoretically repay 0% of its total liabilities (฿4.37 Billion) in one year. See MEGA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mega Lifesciences Public Company Limited Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Mega Lifesciences Public Company Limited across 14 annual periods. For the full cash flow conversion analysis, see Mega Lifesciences Public Company Limited (MEGA) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Mega Lifesciences Public Company Limited (2011–2024)
Year-by-year debt coverage analysis for Mega Lifesciences Public Company Limited. Check MEGA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (THB) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | ฿2.40 Billion | ฿4.33 Billion | ▲ +50.1% |
| 2023 | 0.37x | ฿1.93 Billion | ฿5.22 Billion | ▲ +8.6% |
| 2022 | 0.34x | ฿2.00 Billion | ฿5.87 Billion | ▼ -34.6% |
| 2021 | 0.52x | ฿2.73 Billion | ฿5.25 Billion | ▲ +47.1% |
| 2020 | 0.35x | ฿1.63 Billion | ฿4.61 Billion | ▲ +3.0% |
| 2019 | 0.34x | ฿1.50 Billion | ฿4.36 Billion | ▲ +45.9% |
| 2018 | 0.24x | ฿919.36 Million | ฿3.91 Billion | ▼ -11.8% |
| 2017 | 0.27x | ฿927.00 Million | ฿3.48 Billion | ▼ -31.0% |
| 2016 | 0.39x | ฿1.26 Billion | ฿3.26 Billion | ▲ +108.0% |
| 2015 | 0.19x | ฿609.12 Million | ฿3.28 Billion | ▼ -17.0% |
| 2014 | 0.22x | ฿614.22 Million | ฿2.74 Billion | ▲ +36.6% |
| 2013 | 0.16x | ฿465.77 Million | ฿2.84 Billion | ▲ +20.2% |
| 2012 | 0.14x | ฿342.02 Million | ฿2.51 Billion | ▲ +0.8% |
| 2011 | 0.14x | ฿266.67 Million | ฿1.97 Billion | — |